Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMATE.L Regulatory News (MATE)

  • There is currently no data for MATE

Annual overview from QuotedData

3 May 2023 17:17

RNS Number : 3285Y
JPMorgan Multi-Asset Grwth & Income
03 May 2023
 

JPMorgan Multi-Asset Growth & Income - Annual overview from QuotedData

3rd May 2023

Caution in the face of volatile markets

In a world of volatile equity markets and uncertain futures, MATE offers investors a refreshingly straightforward target of achieving an average of 6% compound annual returns over a rolling five-year period and paying an inflation-linked dividend.

MATE has now passed its five-year anniversary, and its life has been marked by two of the worst bear markets in recent memory. Given that we are in the grip of a painful downturn, it is unsurprising that MATE has fallen short of its target return. Commendably, the team has not taken on more risk in an attempt to catch up. As evidence of this, the standard deviation of MATE's net asset value (NAV) returns over the past five years is half that of the global equity market.

MATE's commitment to providing an attractive and growing income, is supported by its revised dividend policy. Its combination of target long-term returns and attractive income remains its defining feature, and one which sets it apart from its peers. MATE has also been able to sustain a narrow discount throughout 2022, and its shares currently trade on 3.3% discount to NAV.

Full Research:

https://quoteddata.com/research/jpmorgan-multiasset-growth-income-caution-face-volatile-markets-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on JPMorgan Multi-Asset Growth & Income Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUOANROVUVRAR
Date   Source Headline
5th Apr 202310:51 amRNSNet Asset Value(s)
4th Apr 202310:43 amRNSNet Asset Value(s)
3rd Apr 20235:12 pmRNSTransaction in Own Shares
3rd Apr 20231:14 pmRNSGearing Announcement
3rd Apr 202311:14 amRNSNet Asset Value(s)
3rd Apr 20239:53 amRNSTotal Voting Rights
31st Mar 202311:35 amRNSNet Asset Value(s)
31st Mar 202310:36 amRNSTen Largest Investments
30th Mar 202311:15 amRNSNet Asset Value(s)
29th Mar 202310:35 amRNSNet Asset Value(s)
28th Mar 202310:59 amRNSNet Asset Value(s)
27th Mar 202312:29 pmRNSGearing announcement
27th Mar 202311:40 amRNSNet Asset Value(s)
24th Mar 20232:47 pmRNSTransaction in Own Shares
24th Mar 202311:03 amRNSNet Asset Value(s)
23rd Mar 202311:19 amRNSNet Asset Value(s)
23rd Mar 20239:16 amRNSDividend Declaration
22nd Mar 202312:42 pmRNSNet Asset Value(s)
21st Mar 202310:18 amRNSNet Asset Value(s)
20th Mar 202312:50 pmRNSGearing Announcement
20th Mar 202312:06 pmRNSNet Asset Value(s)
17th Mar 20234:55 pmRNSTransaction in Own Shares
17th Mar 202311:27 amRNSNet Asset Value(s)
16th Mar 202310:59 amRNSNet Asset Value(s)
15th Mar 202310:26 amRNSNet Asset Value(s)
14th Mar 202310:56 amRNSNet Asset Value(s)
13th Mar 202311:52 amRNSGearing Announcement
13th Mar 202311:19 amRNSNet Asset Value(s)
10th Mar 202310:57 amRNSNet Asset Value(s)
9th Mar 202310:25 amRNSNet Asset Value(s)
8th Mar 202310:17 amRNSNet Asset Value(s)
7th Mar 202310:39 amRNSNet Asset Value(s)
6th Mar 202312:23 pmRNSGearing Announcement
6th Mar 202311:23 amRNSNet Asset Value(s)
3rd Mar 20231:08 pmRNSNet Asset Value(s)
2nd Mar 202311:16 amRNSNet Asset Value(s)
1st Mar 202311:37 amRNSNet Asset Value(s)
1st Mar 202311:00 amRNSTotal Voting Rights
1st Mar 202310:53 amRNSClosed Period Notification
28th Feb 20235:03 pmRNSTransaction in Own Shares
28th Feb 202310:55 amRNSNet Asset Value(s)
27th Feb 202312:20 pmRNSGearing Announcement
27th Feb 202311:15 amRNSNet Asset Value(s)
24th Feb 202311:23 amRNSNet Asset Value(s)
23rd Feb 202310:52 amRNSNet Asset Value(s)
22nd Feb 202311:04 amRNSNet Asset Value(s)
21st Feb 202310:42 amRNSNet Asset Value(s)
20th Feb 202311:56 amRNSGearing Announcement
20th Feb 202311:41 amRNSNet Asset Value(s)
17th Feb 202312:21 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.